Year: 2021

TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Company”) (TSX VENTURE: GWA) announced today that it intends to settle up to an aggregate of $240,583 of indebtedness (the “Debt Settlement”) through the issuance of common shares of the Company. Pursuant to the proposed Debt Settlement, the Company will issue 1,503,644 common shares, at a deemed price of $0.16 per share, to non-management directors of the Company, in satisfaction of director fees owing and outstanding to such individuals as of October 31, 2021. The Company has elected to settle the indebtedness through the issuance of common shares to preserve cash and improve the Company’s balance sheet. The Debt Settlement is subject to the approval of the TSX Venture Exchange. All of the securities issuable in connection with the Debt Settlement will...

VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) — Fantasy 360 Technologies Inc. d/b/a Immersive Tech (“Immersive Tech” or the “Company”) (CSE:VRAR) (FSE: 79W) (OTCQB: FNTTF) is pleased to announce that it has entered into a loan agreement between the Company and Westdale Construction Co. Limited (“Westdale”) dated December 17 whereby the Company will borrow up to an aggregate of $3,000,000 loan (the “Loan”) and will issue to Westdale 2,000,000 common share purchase warrants (the “Warrants”). Each Warrant will entitle the holder to acquire one common share of the Company at an exercise price of $0.52 for a period of 4 years. “We are very excited to be able to accelerate our mission and continue building the most immersive Metaverse experience in the world. We thank Westdale for their confidence in us and their belief...

During 2022, Enefit Green plans to disclose its production and financial results according to the following schedule:Time ReportWeek 2 Monthly production results (December 2021)Week 6 Monthly production results (January 2022)28.02.2022    Unaudited 2021 annual reportWeek 10 Monthly production results (February 2022)04.04.2022 Audited 2021 annual report and dividend proposal  Week 15 Monthly production results (March 2022)05.05.2022 Unaudited 1Q 2022 reportWeek 19 Monthly production results (April 2022)Week 23 Monthly production results (May 2022)Week 28 Monthly production results (June 2022)04.08.2022 Unaudited 2Q 2022 reportWeek 32 Monthly production results (July 2022)Week 37 Monthly production results (August 2022)Week 41 Monthly production results (September 2022)03.11.2022 Unaudited...

VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) — Icanic Brands Company Inc. (“Icanic” or the “Company”) (TSX-V: ICAN) is providing this update on the status of a management cease trade order granted on November 30, 2021 (the “MCTO”) by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order (“NP 12-203”). On November 30, 2021, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’s discussion and analysis for the fiscal year ended July 31, 2021 (the “Annual Filings”) beyond the period prescribed under applicable Canadian securities laws (the “Default Announcement”). The Company reports that it anticipates filing the...

TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) — Shawcor Ltd. (“Shawcor” or the “Company”) (TSX: SCL) today announced that it has sold its Shawcor Inspection Services (“SIS”) business to Superior Integrity Inc (“Superior”) for approximately C$11.5 million. The SIS business, reported within the Company’s Pipeline and Pipe Services segment, offers non-destructive testing services and related technologies to the US onshore pipeline market. It generated revenue of approximately C$38.4 million with a loss of C$3.3 million on an adjusted EBITDA basis in the twelve months ending September 30, 2021. Proceeds from the sale will be used to reduce the Company’s existing indebtedness. “This sale further demonstrates Shawcor’s strategic commitment to an optimized business portfolio, prioritizing the development and delivery of differentiated, high...

Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement productsNEW YORK, NY and TEL AVIV, Israel , Dec. 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has appointed Mr. Valentino Smith, MBA as Vice President of Marketing. Mr. Smith brings over ten years of marketing experience to Todos, including brick & mortar and digital marketing for consumer packaged goods, healthcare services & information, over-the-counter (OTC) supplement and pharmaceutical products.  “I am very excited to be joining Todos, especially as the Company begins to market Tollovid and Tollovid Daily, and as the Company prepares to...

re+PLAY(TM)re+PLAY(TM) – a Harrington Wellness productre+PLAY is a sports performance and recovery-focused brand founded by NBA veteran Al Harrington with and evidence-based CBD formulations developed in partnership with Avicanna Products will be available across adult use channels in Alberta and Ontario and medical channels in partnership with Medical Cannabis by Shoppers™ This marks the 4th brand and 17th SKU Avicanna has commercialized in the Canadian market TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce the launch of re+PLAY sports recovery-based CBD brand through...

Company Provides Novel Solution for Covid-19 Testing Gap with AptameX™, its Highly Effective and Low-Cost DNA Aptamer-Based Technology for the Detection of Covid-19 and its Variants. AptameX Represents the First Massive Use of DNA Aptamers at Scale Versus Classical Antigenic Approaches to Rapid TestsAptameX™ : Achiko’s DNA Aptamer-Based Covid-19 Rapid TestAptameX™ : Achiko’s DNA Aptamer-Based Covid-19 Rapid TestZURICH, Switzerland, Dec. 20, 2021 (GLOBE NEWSWIRE) — Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468; www.achiko.com) (“Achiko”, the “Company”), a global healthtech company which has developed technologies that deliver rapid, affordable diagnostic testing for Covid-19, associated variants, and a range of other pathogenic diseases and therapeutic indications, is pleased to announce that the Company’s...

Minim, Inc.Jeff Rodning joins Minim as Director, National Retail Sales.MANCHESTER, NH , Dec. 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Minim, Inc. (NASDAQ: MINM), the creator of intelligent networking products under the globally recognized Motorola brand, today welcomes Jeff Rodning as Director, National Retail Sales. “I am excited to welcome Jeff to the team,” said Gray Chynoweth, CEO of Minim. “The US retail market for intelligent connectivity products is strong and poised for continued growth. With our recent software-driven product introductions and expansion into the mesh WiFi category, we needed a leader with deep experience in growing market share with retail leaders like Best Buy and Target.” Jeff Rodning joins Minim as Director, National Retail Sales, effective today. Located in Minneapolis, MN, Jeff...

CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its Board of Directors has authorized a program to repurchase up to $50 million of the Company’s outstanding stock. The share repurchase authorization is effective immediately and valid through December 31, 2023. This program is equivalent to approximately 18 percent of KemPharm’s current market capitalization. “The Board’s decision to establish this share repurchase program reflects the positive momentum underway across all elements of our business, including our outlook for the ongoing commercialization of AZSTARYS®, our strong balance sheet, and the expectations we have for 2022 and beyond, coupled with the strong belief that...